{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:34:28Z","timestamp":1776922468580,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vascn.2025.108391","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:53:28Z","timestamp":1755741208000},"page":"108391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Safety Pharmacology: Achieving a quarter century milestone as a scientific discipline"],"prefix":"10.1016","volume":"135","author":[{"given":"Michael K.","family":"Pugsley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett R.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Tichenor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Authier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniya E.","family":"Koshman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystle G.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2025.108391_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107742","article-title":"The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs","volume":"133","author":"Abernathy","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107764","article-title":"Implementation of automated blood sampling in a canine cardiovascular safety pharmacology study to support PK\/PD assessment","volume":"135","author":"Alizadeh","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0015","first-page":"50363","article-title":"S7A safety pharmacology studies for human pharmaceuticals. International council for harmonisation of technical requirements for pharmaceuticals for human use","volume":"86","author":"Anonymous","year":"2001","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2025.108391_bb0020","first-page":"61133","article-title":"ICH S7B: The nonclinical evaluation of the potential fro delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. International council for harmonisation of technical requirements for pharmaceuticals for human use","volume":"70","author":"Anonymous","year":"2005","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2025.108391_bb0025","first-page":"61134","article-title":"ICH E14: The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Internal council for harmonisation of technical requirements for pharmaceuticals for human use","volume":"69","author":"Anonymous","year":"2005","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2025.108391_bb0030","author":"Anonymous"},{"key":"10.1016\/j.vascn.2025.108391_bb0035","author":"Anonymous"},{"key":"10.1016\/j.vascn.2025.108391_bb0040","author":"Anonymous"},{"key":"10.1016\/j.vascn.2025.108391_bb0050","first-page":"61753","volume":"85","author":"Anonymous","year":"2022","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2025.108391_bb0055","article-title":"ICH E14\/S7B implementation working group: E14\/S7B questions and answers: Clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential","author":"Anonymous","year":"2022","journal-title":"Training Materials."},{"key":"10.1016\/j.vascn.2025.108391_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vascn.2016.06.001","article-title":"Safety pharmacology investigations on the nervous system: An industry survey","volume":"81","author":"Authier","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.108378","article-title":"Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey","volume":"135","author":"Authier","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-662-46943-9_1","article-title":"A historical view and vision into the future of the field of safety pharmacology","volume":"229","author":"Bass","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.vascn.2025.108391_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2004.02.004","article-title":"Introduction to nonclinical safety pharmacology and the safety pharmacology society","volume":"49","author":"Bass","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0080","doi-asserted-by":"crossref","first-page":"107757","DOI":"10.1016\/j.vascn.2025.107757","article-title":"Telemetry in toxicology studies - a comparison of data across species, technologies and time","volume":"134","author":"Best","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.108387","article-title":"Legacy hERG study data in contemporary integrated risk assessments - mitigating the risk of protocol and positive control article differences","volume":"135","author":"Daniels","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107740","article-title":"Surgical instrumentation of cardiovascular telemetry device has minimal impact on the general toxicology data interpretation in Cynomolgus monkeys","volume":"133","author":"Fang","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105706","article-title":"Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation","volume":"153","author":"Friedrichs","year":"2024","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2025.108391_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70249","article-title":"Restraint-based ECG and arterial pressure assessment do not reliably detect drug induced QTc prolongation and hypotension: Evidence from case studies","volume":"18","author":"Henderson","year":"2025","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.vascn.2025.108391_bb0105","doi-asserted-by":"crossref","first-page":"108384","DOI":"10.1016\/j.vascn.2025.108384","article-title":"Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model","author":"Imredy","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107109","article-title":"Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins","volume":"111","author":"Koshman","year":"2021","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0115","doi-asserted-by":"crossref","unstructured":"Kremer J.J., Bridgland-Taylor, M., Clark M., Rolf, M.G., Traebert M., Friedrichs, G.S. (2025). Taking a deep breath: Evidence-based approaches to respiratory safety assessment. Journal of Pharmacological and Toxicological Methods. 2025 Jun;134:107744. doi: https:\/\/doi.org\/10.1016\/j.vascn.2025.107744.","DOI":"10.1016\/j.vascn.2025.107744"},{"key":"10.1016\/j.vascn.2025.108391_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/laban.1217","article-title":"Improving quality of science through better animal welfare: The NC3Rs strategy","volume":"46","author":"Prescott","year":"2017","journal-title":"Lab Animal"},{"issue":"7","key":"10.1016\/j.vascn.2025.108391_bb0125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrd1131","article-title":"Making better drugs: Decision gates in non-clinical drug development","volume":"2","author":"Pritchard","year":"2003","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.vascn.2025.108391_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vascn.2004.03.011","article-title":"Safety pharmacology matures into a unique pharmacological discipline","volume":"49","author":"Pugsley","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"Pt 1","key":"10.1016\/j.vascn.2025.108391_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vascn.2017.08.002","article-title":"The safety pharmacology society salary survey","volume":"88","author":"Pugsley","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0140","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bjp.2008.280","article-title":"Principles of safety pharmacology","volume":"154","author":"Pugsley","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2025.108391_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vascn.2018.01.001","article-title":"An overview of the safety pharmacology society strategic plan","volume":"93","author":"Pugsley","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0150","doi-asserted-by":"crossref","first-page":"107746","DOI":"10.1016\/j.vascn.2025.107746","article-title":"The 2023 safety pharmacology society (SPS) salary survey","volume":"134","author":"Pugsley","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2017.04.012","article-title":"Safety pharmacology methods and models in an evolving regulatory environment","volume":"87","author":"Pugsley","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107089","article-title":"Safety pharmacology during the COVID pandemic","volume":"111","author":"Pugsley","year":"2021","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2010.06.003","article-title":"Non-clinical models: Validation, study design and statistical consideration in safety pharmacology","volume":"62","author":"Pugsley","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0170","doi-asserted-by":"crossref","first-page":"107533","DOI":"10.1016\/j.vascn.2024.107533","article-title":"Innovative approaches to cardiovascular safety pharmacology assessment","volume":"128","author":"Pugsley","year":"2024","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.108377","article-title":"Characterization of a human wearable ECG device for continuous data collection in freely moving non-rodents","volume":"135","author":"Regan","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"121","key":"10.1016\/j.vascn.2025.108391_bb0180","article-title":"Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14\/S7B Q&as","volume":"2023","author":"Rossman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.992650","article-title":"Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac Purkinje cells for proarrhythmia risk prediction","volume":"4","author":"Trovato","year":"2022","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2025.108391_bb0190","article-title":"Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studies","volume":"135","author":"Valentin","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107763","article-title":"Results from an EFPIA, JPMA, PhRMA industry survey on reopening and revamping the ICH S7A guidance on safety and secondary pharmacology","volume":"135","author":"Valentin","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105368","article-title":"2000-2023 over two decades of ICH S7A: Has the time come for a revamp?","volume":"139","author":"Valentin","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2025.108391_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105795","article-title":"Points to consider for revising the ICH S7A guideline on safety and secondary pharmacology","volume":"159","author":"Valentin","year":"2025","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2025.108391_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107265","article-title":"Improving the in vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute","volume":"121","author":"Vargas","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108391_bb0215","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/jama.2024.16911","article-title":"Differential legal protections for biologics vs small-molecule drugs in the US","volume":"332","author":"Wouters","year":"2024","journal-title":"Journal of the American Medical Association"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925008111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925008111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:20:16Z","timestamp":1760214016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871925008111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"alternative-id":["S1056871925008111"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108391","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety Pharmacology: Achieving a quarter century milestone as a scientific discipline","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108391"}}